TP53 and neoplasm: Daige and colleagues showed that the therapeutic miR-34a mimic, delivered by a liposome system in rodents, mainly reached the liver and the tumor as target tissue and was able to reduce the tumor weight and increase p53 expression levels without evidence of any immune response in mice nor in human whole-blood samples, as tested by the presence of cytokines [90].